Literature DB >> 6311890

Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidism.

M Peracchi, F Bamonti-Catena, L Lombardi, E Reschini, V Toschi, A T Maiolo, E E Polli.   

Abstract

Plasma levels and 24-h urinary excretion of cyclic AMP and cyclic GMP were measured in 18 patients with hyperthyroidism, 7 patients with hypothyroidism and 25 normal subjects. Mean plasma and urinary levels of both cyclic AMP and cyclic GMP were significantly positive correlations between the serum thyroid hormone levels and plasma and urinary cyclic nucleotide concentrations were also found, suggesting that the elevated extracellular cyclic nucleotide levels in hyperthyroidism are probably a consequence of increased secretion of thyroid hormones. In the hypothyroid patients the extracellular cyclic nucleotide concentrations did not differ significantly from those of the normal subjects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311890     DOI: 10.1007/BF03350603

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Plasma cyclic nucleotide levels in hyperthyroidism.

Authors:  T Lin
Journal:  Acta Endocrinol (Copenh)       Date:  1979-01

2.  Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.

Authors:  R S Elkeles; J H Lazarus; K Siddle; A K Campbell
Journal:  Clin Sci Mol Med       Date:  1975-01

3.  Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.

Authors:  O R Nilsson; R G Andersson; B E Karlberg
Journal:  Acta Endocrinol (Copenh)       Date:  1980-05

4.  Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism.

Authors:  B E Karlberg; K G Henriksson; R G Andersson
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

5.  Influence of hyperthyroidism on the effects of norepinephrine on myocardial adenyl cyclase activity and contractile state.

Authors:  G S Levey; C L Skelton; S E Epstein
Journal:  Endocrinology       Date:  1969-12       Impact factor: 4.736

6.  Lipolytic action of 3,3'5-triiodo-L-thyronine, a cyclic AMP phosphodiesterase inhibitor.

Authors:  L R Mandel; F A Kuehl
Journal:  Biochem Biophys Res Commun       Date:  1967-07-10       Impact factor: 3.575

7.  Epinephrine-induced alterations in urinary cyclic AMP in hyper- and hypothyroidism.

Authors:  R B Guttler; J W Shaw; C L Otis; J T Nicologg
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

8.  The effect of treatment of hyper- and hypothyroidism on urinary excretion of cyclic adenosine 3',5'-monophosphate.

Authors:  D J Carter; D A Heath
Journal:  Acta Endocrinol (Copenh)       Date:  1977-03

9.  Thyroid function and plasma cyclic AMP response to intravenous glucagon.

Authors:  S N Madsen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-08

10.  Rat liver adenyl cyclase activity in various thyroid states.

Authors:  J K Jones; F Ismail-Beigi; I S Edelman
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

View more
  1 in total

1.  Duodenal mucosa and extracellular cyclic nucleotide pattern in coeliac disease.

Authors:  M Peracchi; F Bamonti-Catena; P Faggioli; N Molteni; M T Bardella; B Bareggi; P A Bianchi
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.